138 related articles for article (PubMed ID: 23763827)
1. Common genetic variants in the microRNA biogenesis pathway are associated with malignant peripheral nerve sheath tumor risk in a Chinese population.
Weng Y; Chen Y; Chen J; Liu Y; Bao T
Cancer Epidemiol; 2013 Dec; 37(6):913-6. PubMed ID: 23763827
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.
Jiang Y; Chen J; Wu J; Hu Z; Qin Z; Liu X; Guan X; Wang Y; Han J; Jiang T; Jin G; Zhang M; Ma H; Wang S; Shen H
Int J Cancer; 2013 Nov; 133(9):2216-24. PubMed ID: 23629745
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis.
Weng Y; Chen Y; Chen J; Liu Y; Bao T
Med Oncol; 2013 Jun; 30(2):531. PubMed ID: 23483452
[TBL] [Abstract][Full Text] [Related]
4. Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
Danielsen SA; Lind GE; Kolberg M; Høland M; Bjerkehagen B; Sundby Hall K; van den Berg E; Mertens F; Smeland S; Picci P; Lothe RA
Neuro Oncol; 2015 Jan; 17(1):63-9. PubMed ID: 25038505
[TBL] [Abstract][Full Text] [Related]
5. TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.
Park GH; Lee SJ; Yim H; Han JH; Kim HJ; Sohn YB; Ko JM; Jeong SY
Oncol Rep; 2014 Oct; 32(4):1347-54. PubMed ID: 25109740
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
7. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
[TBL] [Abstract][Full Text] [Related]
9. Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Kartal P; Vriends ALM; French PJ; van Royen ME; Taal W; Sleijfer S; Wiemer EAC
Sci Rep; 2020 Feb; 10(1):2927. PubMed ID: 32076030
[TBL] [Abstract][Full Text] [Related]
10. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
11. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
12. The promise of signal transduction in genetically driven sarcomas of the nerve.
Kim A; Pratilas CA
Exp Neurol; 2018 Jan; 299(Pt B):317-325. PubMed ID: 28859862
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.
Longo JF; Weber SM; Turner-Ivey BP; Carroll SL
Adv Anat Pathol; 2018 Sep; 25(5):353-368. PubMed ID: 29762158
[TBL] [Abstract][Full Text] [Related]
14. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.
Sung H; Jeon S; Lee KM; Han S; Song M; Choi JY; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
BMC Cancer; 2012 May; 12():195. PubMed ID: 22639842
[TBL] [Abstract][Full Text] [Related]
15. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.
McCaughan JA; Holloway SM; Davidson R; Lam WW
J Med Genet; 2007 Jul; 44(7):463-6. PubMed ID: 17327286
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in microRNA biogenesis pathway genes are associated with semen quality in a Han-Chinese population.
Qin Y; Xia Y; Wu W; Han X; Lu C; Ji G; Chen D; Wang H; Song L; Wang S; Wang X
Reprod Biomed Online; 2012 Apr; 24(4):454-61. PubMed ID: 22381205
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.
Qian F; Feng Y; Zheng Y; Ogundiran TO; Ojengbede O; Zheng W; Blot W; Ambrosone CB; John EM; Bernstein L; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Press MF; Nathanson KL; Hennis A; Nemesure B; Ambs S; Kolonel LN; Olopade OI; Haiman CA; Huo D
Hum Genet; 2016 Oct; 135(10):1145-59. PubMed ID: 27380242
[TBL] [Abstract][Full Text] [Related]
18. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.
Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J
Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697
[TBL] [Abstract][Full Text] [Related]
19. SNP Variation in MicroRNA Biogenesis Pathway Genes as a New Innovation Strategy for Alzheimer Disease Diagnostics: A Study of 10 Candidate Genes in an Understudied Population From the Eastern Mediterranean.
Görücü Yilmaz Ş; Erdal ME; Avci Özge A; Sungur MA
Alzheimer Dis Assoc Disord; 2016; 30(3):203-9. PubMed ID: 26796812
[TBL] [Abstract][Full Text] [Related]
20. A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(5):5113-20. PubMed ID: 26191206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
